Trade Delcath Systems, Inc. - DCTH CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.07 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023512% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00129% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 15.5 |
| Open | 15.22 |
| 1-Year Change | 263.25% |
| Day's Range | 14.81 - 15.6 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 21, 2025 | 14.84 | -0.68 | -4.38% | 15.52 | 15.75 | 14.78 |
| Feb 20, 2025 | 15.50 | 0.01 | 0.06% | 15.49 | 15.66 | 15.19 |
| Feb 19, 2025 | 15.69 | -0.34 | -2.12% | 16.03 | 16.27 | 15.66 |
| Feb 18, 2025 | 16.26 | 0.26 | 1.63% | 16.00 | 16.33 | 15.69 |
| Feb 14, 2025 | 16.16 | -0.07 | -0.43% | 16.23 | 16.35 | 15.75 |
| Feb 13, 2025 | 16.21 | 0.42 | 2.66% | 15.79 | 16.32 | 15.59 |
| Feb 12, 2025 | 15.73 | 0.15 | 0.96% | 15.58 | 15.97 | 15.48 |
| Feb 11, 2025 | 15.89 | 0.01 | 0.06% | 15.88 | 16.03 | 15.48 |
| Feb 10, 2025 | 16.02 | -0.31 | -1.90% | 16.33 | 16.66 | 15.98 |
| Feb 7, 2025 | 16.23 | -0.28 | -1.70% | 16.51 | 16.83 | 15.97 |
| Feb 6, 2025 | 16.41 | 0.14 | 0.86% | 16.27 | 16.50 | 15.99 |
| Feb 5, 2025 | 16.26 | -0.07 | -0.43% | 16.33 | 16.64 | 15.68 |
| Feb 4, 2025 | 16.21 | 0.73 | 4.72% | 15.48 | 16.28 | 15.48 |
| Feb 3, 2025 | 15.41 | 0.18 | 1.18% | 15.23 | 15.76 | 14.98 |
| Jan 31, 2025 | 15.58 | -0.27 | -1.70% | 15.85 | 16.23 | 15.57 |
| Jan 30, 2025 | 15.92 | 0.19 | 1.21% | 15.73 | 16.09 | 15.73 |
| Jan 29, 2025 | 15.59 | -0.03 | -0.19% | 15.62 | 16.01 | 15.35 |
| Jan 28, 2025 | 15.82 | 0.43 | 2.79% | 15.39 | 15.96 | 14.85 |
| Jan 27, 2025 | 15.43 | -0.10 | -0.64% | 15.53 | 15.74 | 14.94 |
| Jan 24, 2025 | 15.96 | -0.12 | -0.75% | 16.08 | 16.40 | 15.54 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Delcath Systems, Inc. Company profile
About Delcath Systems Inc
Delcath Systems, Inc. is an oncology company. The Company is focused on the treatment of primary and metastatic liver cancers. The Company is a specialty pharmaceutical and medical device company developing its products. The Company's lead product candidate is HEPZATO KIT (melphalan hydrochloride for injection/hepatic delivery system) is a drug/device combination product. HEPZATO is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The Company's focus is on the execution of the clinical development program (CDP) in ocular melanoma liver metastases (mOM), intrahepatic cholangiocarncinoma (ICC), hepatocellular carcinoma (HCC or primary liver) and other cancers that are metastatic to the liver.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Delcath Systems Inc revenues increased 27% to $1.4M. Net loss applicable to common stockholders increased 18% to $20.3M. Revenues reflect Product revenue increase of 35% to $1.1M, Other revenue increase of 9% to $392K. Higher net loss reflects Research and development expenses increase from $3M to $8.3M (expense), Stock-based Compensation in SGA increase from $49K to $4.2M (expense), Selling.
Equity composition
Common Stock $.01 Par, 12/10, 70M auth., 43,028,146 issd., less 28,100 shares in Treas. @ $51.1M. Insiders control 1.42%. InitialPublic Offering 10/20/00, 1.2M Units (1 Common+ 1Redeemable Warrant) @ $6 by Whale Securities Co . 5/20/03,Company sold 677,419 Units (5 Common + 5 Warrants) @ $3.10/unit. 98.3. 04/14, 1-for-16 Reverse stock split.
| Industry: | Medical Prosthetics |
1633 Broadway Ste 22C
NEW YORK
NEW YORK 10019-6708
US
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com